To this aim, we measured the co-effect of inhibiting the transcription factor NF-κB combined with TMZ in human GBM spheroids derived from cell lines (U87 and LN229) [32], as well as in patient-derived GBM spheroids. This evidence concerns the gene NFKB1 and glioblastoma.